Esta traducción se está preparando. Mientras tanto, mostramos temporalmente la versión original en inglés.
Negocios · 12/5/19981 min de lectura
Pfizer, Inc.; Withdrawal of Approval of NADA's
Traducción automática local · Idioma original de la fuente
Resumen
The Food and Drug Administration (FDA) is withdrawing approval of four new animal drug applications (NADA's) held by Pfizer, Inc. The NADA's provide for use of oxytetracycline hydrochloride. The sponsor requested the withdrawal of approval of the NADA's because the animal drug products are no longer manufactured or marketed.
Idioma original de la fuente: Federal Register — Food and Drug AdministrationAbrir el comunicado original →